Prot#1245-0137: A Multicentre International Randomized Parallel Group Double-Blind Placebo-Controlled Clinical Trial of EMPAgliflozin Once Daily to Assess Cardio-Renal Outcomes in Patients with Chronic KIDNEY Disease

Project: Research project

Project Details

StatusActive
Effective start/end date4/19/19 → 10/31/26

Funding

  • Duke Clinical Research Institute (Prot#1245-0137 // Prot#1245-0137)
  • Boehringer Ingelheim International GmbH (Prot#1245-0137 // Prot#1245-0137)